By rray, 25 January, 2024 If symptomatic rhythm control can improve sx If uncertain about sx being due to AF rhythm control trial may clarify
By rray, 25 January, 2024 If reduced LV function trial of rhythm control recommended to evaluate if AF is contributing to reduced LV function
By rray, 25 January, 2024 Long term anticoagulation reasonable if nbsp nbsp Treatable GI pulmonary or GU system nbsp nbsp Bleeding related to isolated trauma nbsp nbsp Bleeding related to procedural complications
By rray, 25 January, 2024 Contraindications to long term anticoagulation nbsp nbsp Severe bleeding due to a nonreversible cause involving the GI pulmonary or GU systems nbsp nbsp Spontaneous intracranial intraspinal bleeding due to a nonreversible cause nbsp nbsp Serious bleeding
By rray, 25 January, 2024 Evaluate for bleeding risks prior bleeding anemia meds Bleeding risk scores perform poorly Do not use in isolation ESC recommends HAS BLED score 1
By rray, 25 January, 2024 If congenital heart dz or HCM anticoagulate regardless of stroke risk score
By rray, 25 January, 2024 Use validated score e g CHA2DS2 VASc If male pt w CHA2DS2 VASc score of 1 or female pt w CHA2DS2 VASc score of 2 remains uncertain about the benefit of anticoagulation consider other factors that might modify their stroke risk to help inform the decision